AmBisome liposomal formulation of the antifungal drug amphotericin B: Partner Fujisawa USA Inc. began a Phase III trial in 660 patients with fever suspected to

NeXstar Pharmaceuticals Inc. (NXTR), Boulder, Colo. Product: AmBisome liposomal formulation of the antifungal drug amphotericin B Indication: Fever of unknown origin in cancer Status: Partner Fujisaw...